Skip Navigation
Skip to contents

ICoLA 2019

Today : 2019.08.26
D- 10
The 8th International Congress on Lipid & Atherosclerosis (ICoLA)
The 58th Fall Conference of the Korean Society of Lipid & Atherosclerosis
September 5 (Thu) ~ 7 (Sat), 2019
Conrad Seoul Hotel, Korea

Breakfast Symposia

  • HOME
  • Program
  • Breakfast Symposia

*(K) Korean Session

BREAKFAST SYMPOSIUM 1
Sep. 6 (Fri.)
08:00~09:00
Room 1

more

Chairperson Deuk-Young Nah (Dongguk University, Korea)
08:00-08:05 Opening Remark
08:05-08:25 Moderate Intensity Statin Plus Ezetimibe vs. High Intensity Statin in Hypercholesterolemia Patients with CHD Risk Kwan Yong Lee (The Catholic University of Korea) Abstract
08:25-08:45 New Treatment Options for SGLT2 Inhibitor in Patients with Type 2 Diabetes Seung-Hwan Lee (The Catholic University of Korea) Abstract
08:45-08:55 Discussion
BREAKFAST SYMPOSIUM 2
Sep. 6 (Fri.)
08:00~09:00
Room 2

more

Chairperson Jeong Euy Park (Park Jeong Euy Internal Medicine Clinic, Korea)
08:00-08:20 A New and Powerful Solution for Dyslipidemia in Hypertension Kyung Woo Park (Seoul National University, Korea)
08:20-08:40 Beyond LDL-C Lowering Effect Kwang-il Kim (Seoul National University, Korea) Abstract
BREAKFAST SYMPOSIUM 3
Sep. 6 (Fri.)
08:00~09:00
Room 3

more

Chairperson Doo Man Kim (Hallym University, Korea)
08:00-08:20 Atorvastatin Safety Study for Korean DyslipideMia Patients Hyung Joon Joo (Korea University, Korea)
08:20-08:40 LIPILOU-NSC Study : Neurotrophic Effect of Atorvastatin in NSCs Agency Ischemic Injury Seong-Ho Koh (Hanyang University, Korea)  Abstract
BREAKFAST SYMPOSIUM 4
Sep. 7 (Sat.)
08:00~09:00
Room 1

more

Chairperson Sungwoo Park (Sungkyunkwan University, Korea)
08:00-08:30 SGLT2 Inhibitors and Cardiovascular Diseases: Lessons, Learnings and the Future Subodh Verma (University of Toronto, Canada) Abstract
BREAKFAST SYMPOSIUM 5
Sep. 7 (Sat.)
08:00~09:00
Room 2

more

Chairperson Hyun Ho Shin (Dankook University, Korea)
08:00-08:30 PCSK9 Inhibition after Acute Coronary Syndrome: Who Should Be Treated? Gregory G. Schwartz (University of Colorado, USA) Abstract
BREAKFAST SYMPOSIUM 6
Sep. 7 (Sat.)
08:00~09:00
Room 3

more

Chairperson Shung Chull Chae (Kyungpook National University, Korea)
08:00-08:20 Practical Use of PCSK9 Inhibitor in Endocrinology Jun Hwa Hong (Eulji University, Korea) Abstract
08:20-08:40 The Role of Evolocumab in the Management of ASCVD Patients Kyung Woo Park (Seoul National University, Korea)
08:40-08:50 QnA
Organized by KSoLA

The Korean Society of Lipid and Atherosclerosis

No.707, Mapoacro Tower, 68 Mapo-daero, Mapo-gu, Seoul 04168, Korea
  • Business Registration Number : 110-82-60956
  • Chairman : Joong-Yeol Park

Secretariat of ICoLA 2019 │ People & Value, Inc.

#1001 Botanic Park Tower, Magok-joongang-ro 161-17, Gangseo-gu, Seoul, Korea

Copyrights 2019 © The Korean Society of Lipid and Atherosclerosis. All rights reserved.